Back to results
US 2014/0235676 A1Published application
Rxr agonist compounds and methods
OwnerGary E. Landrethinventor
Life of this patent
Estimating the term…
Abstract
A method of treating a psychiatric or cognitive developmental disorder in a subject, includes administering to the subject a therapeutically effective amount of at least one RXR agonist.
Claims21
A method of treating a psychiatric or cognitive developmental disorder in a subject, comprising:
- administering to the subject a therapeutically effective amount of at least one RXR agonist to treat the psychiatric or cognitive developmental disorder.
A method of treating a psychiatric or cognitive developmental disorder in a subject, comprising:
- administering to the subject a therapeutically effective amount of at least one RXR agonist, the RXR agonist comprising:
- or a pharmaceutically acceptable salt thereof to treat the psychiatric or cognitive developmental disorder.
A method of treating a psychiatric or cognitive developmental disorder in a subject, comprising:
- administering to the subject a therapeutically effective amount of at least one RXR agonist to treat the psychiatric or cognitive developmental disorder, the RXR agonist is in micronized form and comprises:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.